Use of 5α-reductase inhibitor and delay in prostate cancer diagnosis and treatment-Reference-Cited by-同舟云学术

Use of 5α-reductase inhibitor and delay in prostate cancer diagnosis and treatment

Published:2020-06 Issue:3 Volume:46 Page:456-458
ISSN:1677-6119
Container-title:International braz j urol
language:
Short-container-title:Int. braz j urol.

Author:

Busato Júnior Wilson F. S.¹^ORCID

Affiliation:

1. Universidade do Vale do Itajaí, Brasil; Sociedade Brasileira de Urologia, Brasil

Publisher

FapUNIFESP (SciELO)

Subject

Urology

Link

http://www.scielo.br/pdf/ibju/v46n3/1677-6119-ibju-46-03-0456.pdf

Reference12 articles.

1. Epidemiology and treatment modalities for the management of benign prostatic hyperplasia;Lokeshwar SD;Transl Androl Urol,2019

2. Medical treatment of benign prostatic hyperplasia;Lepor H;Rev Urol,2011

3. The role of 5-alpha reductase inhibitors in prostate pathophysiology: Is there an additional advantage to inhibition of type 1 isoenzyme?;Goldenberg L;Can Urol Assoc J,2009

4. 5alpha-reductase inhibitors in benign prostatic hyperplasia and prostate cancer risk reduction;Rittmaster RS;Best Pract Res Clin Endocrinol Metab,2008

5. Long-Term Effects of Finasteride on Prostate Cancer Mortality;Goodman PJ;N Engl J Med,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Filamentous Fungi-Derived Orsellinic Acid-Sesquiterpene Meroterpenoids: Fungal Sources, Chemical Structures, Bioactivities, and Biosynthesis;Planta Medica;2023-05-24

2. Rates of False-Negative Screening in Prostate Specific Antigen Secondary to 5-Alpha Reductase Inhibitor Usage: A Quality-Improvement Initiative;International braz j urol;2022-08